Emerge and Engage topline results: Phase 3 studies of aducanumab in early Alzheimer’s disease

Alzheimer s & Dementia ◽

10.1002/alz.047259 ◽

2020 ◽

Vol 16 (S9) ◽

Author(s):

Samantha Budd Haeberlein ◽

Christian von Hehn ◽

Ying Tian ◽

Spyros Chalkias ◽

Kumar Kandadi Muralidharan ◽

...

Keyword(s):

Alzheimer’S Disease ◽

Alzheimer's Disease ◽

Phase 3 ◽

Early Alzheimer’S Disease

Download Full-text

Baseline characteristics for CLARITY AD: A phase 3 placebo‐controlled, double‐blind, parallel‐group, 18‐month study evaluating lecanemab (ban2401) in early Alzheimer's disease

Alzheimer s & Dementia ◽

10.1002/alz.054331 ◽

2021 ◽

Vol 17 (S9) ◽

Author(s):

Shau Yu Lynch ◽

Michael C Irizarry ◽

Shobha Dhadda ◽

David JianJun Li ◽

Michio Kanekiyo ◽

...

Keyword(s):

Alzheimer’S Disease ◽

Alzheimer's Disease ◽

Phase 3 ◽

Double Blind ◽

Parallel Group ◽

Baseline Characteristics ◽

Early Alzheimer’S Disease

Download Full-text

REGIONAL COGNITIVE DIFFERENCES IN REFERRALS TO THE ELENBECESTAT MISSIONAD PHASE 3 PROGRAM IN EARLY ALZHEIMER’S DISEASE

Alzheimer s & Dementia ◽

10.1016/j.jalz.2019.06.072 ◽

2019 ◽

Vol 15 (7) ◽

pp. P250-P251

Author(s):

Thomas Doherty ◽

Jennifer Murphy ◽

Julie Marsh ◽

Luke Koschalka ◽

Mairelys Martinez ◽

...

Keyword(s):

Alzheimer’S Disease ◽

Alzheimer's Disease ◽

Phase 3 ◽

Cognitive Differences ◽

Early Alzheimer’S Disease

Download Full-text

Subgroup analyses of the amyloid PET substudies from EMERGE and ENGAGE, phase 3 clinical trials evaluating aducanumab in patients with early Alzheimer’s disease

Alzheimer s & Dementia ◽

10.1002/alz.057496 ◽

2021 ◽

Vol 17 (S9) ◽

Author(s):

Raj Rajagovindan ◽

Tianle Chen ◽

Hao Wu ◽

Ying Tian ◽

Laura Nisenbaum ◽

...

Keyword(s):

Alzheimer’S Disease ◽

Alzheimer's Disease ◽

Clinical Trials ◽

Amyloid Pet ◽

Phase 3 ◽

Subgroup Analyses ◽

Early Alzheimer’S Disease

Download Full-text

Supplemental Material for Timing Impairments in Early Alzheimer’s Disease: Evidence From a Mouse Model

Behavioral Neuroscience ◽

10.1037/bne0000359.supp ◽

2020 ◽

Keyword(s):

Alzheimer’S Disease ◽

Alzheimer's Disease ◽

Mouse Model ◽

Early Alzheimer’S Disease

Download Full-text

Driver landmark and traffic sign identification in early Alzheimer's disease

Yearbook of Neurology and Neurosurgery ◽

10.1016/s0513-5117(08)70072-3 ◽

2007 ◽

Vol 2007 ◽

pp. 106-107

Author(s):

J.P. Blass

Keyword(s):

Alzheimer’S Disease ◽

Alzheimer's Disease ◽

Traffic Sign ◽

Early Alzheimer’S Disease

Download Full-text

Improvement of mitochondrial function and dynamics by the metabolic enhancer piracetam in a human neuronal cell model of early Alzheimer's disease

Pharmacopsychiatry ◽

10.1055/s-0033-1353305 ◽

2013 ◽

Vol 46 (06) ◽

Author(s):

C Schiller ◽

D Miano ◽

K Leuner ◽

WE Müller

Keyword(s):

Alzheimer’S Disease ◽

Alzheimer's Disease ◽

Mitochondrial Function ◽

Neuronal Cell ◽

Human Neuronal Cell ◽

Early Alzheimer’S Disease

Download Full-text

A Study to Confirm Safety and Efficacy of BAN2401 in Participants With Early Alzheimer's Disease

Case Medical Research ◽

10.31525/ct1-nct03887455 ◽

2019 ◽

Author(s):

Keyword(s):

Alzheimer’S Disease ◽

Alzheimer's Disease ◽

Safety And Efficacy ◽

Early Alzheimer’S Disease

Download Full-text

Faculty Opinions recommendation of Propagation of tau pathology in a model of early Alzheimer's disease.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.13949978.15442075 ◽

2012 ◽

Author(s):

Henry Paulson

Keyword(s):

Alzheimer’S Disease ◽

Alzheimer's Disease ◽

Tau Pathology ◽

Early Alzheimer’S Disease

Download Full-text

Faculty Opinions recommendation of A human stem cell model of early Alzheimer's disease pathology in Down syndrome.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.718018190.793517524 ◽

2016 ◽

Author(s):

André Strydom

Keyword(s):

Alzheimer’S Disease ◽

Alzheimer's Disease ◽

Down Syndrome ◽

Stem Cell ◽

Human Stem Cell ◽

Stem Cell Model ◽

Early Alzheimer’S Disease

Download Full-text

Faculty Opinions recommendation of A human stem cell model of early Alzheimer's disease pathology in Down syndrome.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.718018190.793515497 ◽

2016 ◽

Author(s):

Annette Karmiloff-Smith

Keyword(s):

Alzheimer’S Disease ◽

Alzheimer's Disease ◽

Down Syndrome ◽

Stem Cell ◽

Human Stem Cell ◽

Stem Cell Model ◽

Early Alzheimer’S Disease

Download Full-text